Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Nafronyl oxalate

Related Products

Hot Products

Name

Nafronyl oxalate

EINECS 221-703-0
CAS No. 3200-06-4 Density 1.2205 (rough estimate)
PSA 113.37000 LogP 3.60820
Solubility N/A Melting Point 110-111°
Formula C24H33NO3.C2H2O4 Boiling Point 664.4°C at 760 mmHg
Molecular Weight 473.566 Flash Point 355.6°C
Transport Information N/A Appearance N/A
Safety Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx. Risk Codes R22   
Molecular Structure Molecular Structure of 3200-06-4 (alpha-(1-Naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester oxalate) Hazard Symbols
Synonyms

Naftidrofuryl oxalate; alpha-(1-Naphthylmethyl)-2-tetrahydrofuranpropionic acid diethylaminoethyl ester oxalate

Article Data 2

Nafronyl oxalate Synthetic route

144-62-7

oxalic acid

3200-06-4

Gevatran

Conditions
ConditionsYield
In water; acetone for 1h; Reflux;80%

Nafronyl oxalate Chemical Properties

Product Name: Nafronyl oxalate (CAS NO.3200-06-4)


Molecular Formula: C26H35NO7
Molecular Weight: 473.56g/mol
Mol File: 221-703-0.mol
H-Bond Donor: 2
H-Bond Acceptor: 8
Structure Descriptors of Nafronyl oxalate (CAS NO.3200-06-4):
  IUPAC Name: 2-diethylaminoethyl 2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoate;oxalic acid
  Canonical SMILES: CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=CC=CC3=CC=CC=C32.C(=O)(C(=O)O)O
  InChI: InChI=1S/C24H33NO3.C2H2O4/c1-3-25(4-2)14-16-28-24(26)21(18-22-12-8-15-27-22)17-20-11-7-10-19-9-5-6-13-23(19)20;3-1(4)2(5)6/h5-7,9-11,13,21-22H,3-4,8,12,14-18H2,1-2H3;(H,3,4)(H,5,6) 
  InChIKey: SSAJNPNVUYMUCI-UHFFFAOYSA-N

Nafronyl oxalate Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LDLo intravenous 71mg/kg (71mg/kg)   Chimica Therapeutica. Vol. 3, Pg. 463, 1968.
mouse LD50 intramuscular 696mg/kg (696mg/kg)   Chimica Therapeutica. Vol. 3, Pg. 463, 1968.
mouse LD50 intraperitoneal 159mg/kg (159mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: CYANOSIS

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14, Pg. 1237, 1986.
mouse LD50 intravenous 18400ug/kg (18.4mg/kg)   United States Patent Document. Vol. #4439442,
mouse LD50 oral 365mg/kg (365mg/kg)   United States Patent Document. Vol. #4652583,
mouse LD50 subcutaneous 547mg/kg (547mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14, Pg. 1237, 1986.
rabbit LDLo intravenous 8mg/kg (8mg/kg) AUTONOMIC NERVOUS SYSTEM: "SMOOTH MUSCLE RELAXANT (MECHANISM UNDEFINED, SPASMOLYTIC)"

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 11, Pg. 103, 1985.
rabbit LDLo oral 1gm/kg (1000mg/kg) GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. Vol. 11, Pg. 81, 1985.
rat LD50 intraperitoneal 98mg/kg (98mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14, Pg. 1237, 1986.
rat LD50 intravenous 11080ug/kg (11.08mg/kg)   United States Patent Document. Vol. #4439442,
rat LD50 oral 711mg/kg (711mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14, Pg. 1237, 1986.
rat LD50 subcutaneous 896mg/kg (896mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 14, Pg. 1237, 1986.

Nafronyl oxalate Safety Profile

Poison by intravenous and intraperitoneal routes. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.
Safety Information of Nafronyl oxalate (CAS NO.3200-06-4):
Hazard Codes: XnHarmful,XiIrritant
Risk Statements: 22  
22:  Harmful if swallowed 
Safety Statements: 36
36:  Wear suitable protective clothing   .

Nafronyl oxalate Specification

 Nafronyl oxalate ,its CAS NO. is 3200-06-4,the synonyms is Diethyl(2-(2-(1-naphthylmethyl)-3-(tetrahydro-2-furyl)propionyloxy)ethyl)ammonium hydrogen oxalate ; 2-(Diethylamino)ethyl tetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionate oxalate (1:1) ; Dubimax ; Dusodril ; EINECS 221-703-0 ; EU-1806 ; Gevatran ; Iridus ; LS 121 ; NSC 225233 ; Naftidrofuryl oxalate ; Naphtidrofuryl oxalate ; Praxilene ; UNII-5ADB8D9388 .

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3200-06-4